Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VI. | J Inherit Metab Dis;37(2): 277-87, 2014 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VI.

Harmatz, Paul R; Garcia, Paula; Guffon, Nathalie; Randolph, Linda M; Shediac, Renée; Braunlin, Elizabeth; Lachman, Ralph S; Decker, Celeste.

Affiliation

Harmatz PR; Children's Hospital & Research Center Oakland, 747 52nd Street, Oakland, CA, USA, pharmatz@mail.cho.org.

J Inherit Metab Dis ; 37(2): 277-87, 2014 Mar.

Article in En | MEDLINE | ID: mdl-24108527

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mucopolysaccharidosis VI / N-Acetylgalactosamine-4-Sulfatase / Enzyme Replacement Therapy Type of study: Clinical_trials Limits: Humans / Infant / Male Language: En Journal: J Inherit Metab Dis Year: 2014 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mucopolysaccharidosis VI / N-Acetylgalactosamine-4-Sulfatase / Enzyme Replacement Therapy Type of study: Clinical_trials Limits: Humans / Infant / Male Language: En Journal: J Inherit Metab Dis Year: 2014 Document type: Article Country of publication: